2Baricos WH,Cortez SL,el-DahrSS,et al.ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP22 cascade.Kidney Int.1995,47(4):1039.
3Li JM,Shah AM.ROS generation by nonphagocytic NADPH oxidase:potential relevance in diabetic nephropathy.J Am Soc Nephrol.2003,14(8 Suppl 3):S221.
4Ha H,Lee HB.Reactive oxygen species and matrix remodeling in diabetic kidney.J Am Soc Nephrol.2003,14(8 Suppl 3):S246.
2[2]Brancati FL,Cusumano AM.Epidemiology and prevention of diabetic nephropathy[J].Curr Opin Nephrol Hypertens,1995;4(3):223-229
3[3]Breyer JA.Diabetic nephropathy in insulin-dependent patients[J].Am J Kindey Dis,1992;20:533-547
4[4]Hostetter TH.Early renal function in diabetes and risk factors for development of diabetic nephropathy.in:Jacobson HR,Striker CE,Klahr S,eds.The principles and practice of nephrology[M].Philadelphia BC Decker,1991:460-462
5[5]Mongensen CE.Microalbuminuria as a predictor of clinical diabetic nephropathy[J].Kidney Int,1987;31(2):673-689
6[6]Viberti GC,Wiseman M.The kidney in diabetes:Significance of early abnormalities[J].Clin Endocrinol Metab,1986;9:85-92
7[7]Nielsen S,Schmitz A,Mogensen CE.Rate of progression of nephropathy in normal and microalbuminurial type Ⅱ diabetic patients.Diabetologia[J],1991;34(suppl 2):A144
8[8]Schmitz A.Microalbuminuria and mortality in non-insulin-depen dent diabetes.In:Mogensen CE,ed.The Kidney and Hypertension in Diabetesc[M].Boston:Martinus Nijhoff Publishing,1988:6570
9[9]Christensen CK,Mogensen CE.The course of incipients nephropathy:studies on albumin excretion and blood pressure[J].Diabetic Med,1985;2:97-102
10[10]Gilbert RE,Tsalamandris C,Bach LA et al.Long-term glycaemic control and the rate of progression of early diabetic kidney disease[J].Kidney Int,1993;44:855-859
1Tam F W, Riser B L, Meeran K, et al. Urinary monocyte chemoattractant protein-I (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy[ J]. Cytokine, 2009, 47 (1): 37-42.
2Malik A R, Little M A, Henriksson M, et al. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis[ J]. J Nephrol, 2007, 20(3) : 340-349.
3Sheryanna A M, Smith J, Bhangal G, et al. Treatment with a cyc|in-dependent klnase inhibitor, sellciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis [ J ]. Nephrology (Carlton), 2011, 16(4) : 410-416.
4Behmoaras J, Smith J, D' Souza Z, et al. Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis[J]. J Am Soc Nephrol, 2010, 21 (7) : 1136- 1144.
